Glucagon secretion in chronic pancreatitis.

Area of Science:

• Endocrinology
• Gastroenterology
• Metabolic Research

Background:

• Chronic pancreatitis is a complex endocrine and exocrine disorder.
• Hormonal dysregulation, including insulin and glucagon, is implicated in its pathophysiology.
• Intestinal hormones like enteroglucagon may also be affected.

Purpose of the Study:

• To investigate plasma insulin, pancreatic glucagon, and enteroglucagon levels in patients with chronic pancreatitis.
• To compare hormonal responses to oral glucose and intravenous arginine challenges between patients and healthy controls.
• To elucidate the role of these hormones in the metabolic alterations associated with chronic pancreatitis.

Main Methods:

• Measurement of plasma insulin, pancreatic glucagon, and enteroglucagon.
• Study conducted in 10 patients with chronic pancreatitis and 5 healthy subjects.
• Hormonal levels assessed at basal state and after oral glucose and intravenous arginine stimulation.

Main Results:

• Reduced plasma insulin response to both oral glucose and arginine in chronic pancreatitis patients.
• Increased basal pancreatic glucagon in patients, with further elevation after oral glucose.
• Exaggerated early pancreatic glucagon response to arginine infusion in patients.
• Significantly elevated basal enteroglucagon levels in chronic pancreatitis, with normal responses to stimuli.

Conclusions:

• Chronic pancreatitis is associated with impaired insulin secretion and altered pancreatic glucagon dynamics.
• Elevated basal enteroglucagon suggests a potential role in the disease, though its dynamic response is preserved.
• These hormonal changes contribute to the understanding of metabolic disturbances in chronic pancreatitis.